The vitamin microcapsules, according to Xampla, "increase the volume of effective vitamins without affecting the product's taste."
The NPS has been focusing on anthocyanins, the antioxidant-rich pigments that give blackberries and blueberries their signature shades.
The $300 million investment is described as a way to help farmers and producers of organic products build new and better markets and streams of income.
Costa Rica is one of the best-performing plant-based markets in LAC for Burger King, based on sales of the Veggie Whopper at the company’s retail locations.
Alcoholic product sales are a rich source of taxes for the NTA, which opened up marketing ideas to the general public in their Sake Viva! contest.
Although its Tropicana melon taste juice product was labeled as 100 percent melon by Kirin Holdings, it contained only 2 percent melon juice.
The court found that Pfizer's Direct Copay Assistance Program broke the law by "knowingly or willingly" offering financial support to encourage the purchase of federally reimbursable drugs.
China, the US, and India are expected to bear the brunt of the damage, with costs of $10 trillion, $2.5 trillion, and $850 billion.
How will Delta evolve? Here's what the theory tells us
The COVID-19 pandemic is a dramatic demonstration of evolution in action. Evolutionary theory explains much of what has already happened, predicts what will happen in the future and suggests which management strategies are likely to be the most effective.
For instance, evolution explains why the Delta variant spreads faster than the original Wuhan strain. It explains what we might see with future variants. And it suggests how we might step up public health measures to respond.
But Delta is not the end of the story for SARS-CoV-2, the virus that causes COVID-19. Here’s what evolutionary theory tells us happens next.
Remind me again, how do viruses evolve?
Evolution is a result of random mutations (or errors) in the viral genome when it replicates. A few of these random mutations will be good for the virus, conferring some advantage. Copies of these advantageous genes are more likely to survive into the next generation, via the process of natural selection.
New viral strains can also develop via recombination, when viruses acquire genes from other viruses or even from their hosts.
Generally speaking, we can expect evolution to favour virus strains that result in a steeper epidemic curve, producing more cases more quickly, leading to two predictions.
First, the virus should become more transmissible. One infected person will be likely to infect more people; future versions of the virus will have a higher reproductive or R number.
Second, we can also expect evolution will shorten the time it takes between someone becoming infected and infecting others (a shorter “serial interval”).
Both these predicted changes are clearly good news for the virus, but not for its host.
Aha, so that explains Delta
This theory explains why Delta is now sweeping the world and replacing the original Wuhan strain.
The original Wuhan strain had an R value of 2-3 but Delta’s R value is about 5-6 (some researchers say this figure is even higher). So someone infected with Delta is likely to infect at least twice as many people as the original Wuhan strain.
The Delta variant is an example of how quickly the virus can evolve. Shutterstock
There’s also evidence Delta has a much shorter serial interval compared with the original Wuhan strain.
This may be related to a higher viral load (more copies of the virus) in someone infected with Delta compared with earlier strains. This may allow Delta to transmit sooner after infection.
Do vaccines affect how the virus evolves?
We know COVID-19 vaccines designed to protect against the original Wuhan strain work against Delta but are less effective. Evolutionary theory predicts this; viral variants that can evade vaccines have an evolutionary advantage.
So we can expect an arms race between vaccine developers and the virus, with vaccines trying to play catch up with viral evolution. This is why we’re likely to see us having regular booster shots, designed to overcome these new variants, just like we see with flu booster shots.
There’s a trade-off between transmissibility and how sick a person gets (virulence) with most disease-causing microorganisms. This is because you need a certain viral load to be able to transmit.
If vaccines are not 100% effective in blocking transmission, we can expect a shift in the trade-off towards higher virulence. In other words, a side-effect of the virus being able to transmit from vaccinated people is, over time, the theory predicts it will become more harmful to unvaccinated people.
How about future variants?
In the short term, it’s highly likely evolution will continue to “fine tune” the virus:
its R value will continue to increase (more people will be infected in one generation)
the serial interval will decrease (people will become infectious sooner)
variants will make vaccines less effective (vaccine evasion).
But we don’t know how far these changes might go and how fast this might happen.
The UK government’s Scientific Advisory Group for Emergencies (SAGE) has recently explored scenarios for long-term evolution of the virus.
It says it is almost certain there will be “antigenic drift”, accumulation of small mutations leading to the current vaccines becoming less effective, so boosters with modified vaccines will be essential.
It then says more dramatic changes in the virus (“antigenic shift”), which might occur through recombination with other human coronaviruses, is a “realistic possibility”. This would require more substantial re-engineering of the vaccines.
SAGE also thinks there is a realistic possibility of a “reverse zoonosis”, leading to a virus that may be more pathogenic (harmful) to humans or able to evade existing vaccines. This would be a scenario where SARS-CoV-2 infects animals, before crossing back into humans. We’ve already seen SARS-CoV-2 infect mink, felines and rodents.
Versions of the virus that make their host very sick (are highly virulent) are generally selected against. This is because people would be more likely to die or be isolated, lowering the chance of the virus transmitting to others.
SAGE thinks this process is unlikely to cause the virus to become less virulent in the short term, but this is a realistic possibility in the long-term. Yet SAGE says there is a realistic possibility more virulent strains might develop via recombination (which other coronaviruses are known to do).
So the answer to this critical question is we really don’t know if the virus will become more deadly over time. But we can’t expect the virus to magically become harmless.
Will humans evolve to catch up?
Sadly, the answer is “no”. Humans do not reproduce fast enough, and accumulate enough favourable mutations quickly enough, for us to stay ahead of the virus.
The virus also does not kill most people it infects. And in countries with well-resourced health-care systems, it doesn’t kill many people of reproductive age. So there’s no “selection pressure” for humans to mutate favourably to stay ahead of the virus.
What about future pandemics?
Finally, evolutionary theory has a warning about future pandemics.
A gene mutation that allows a virus in an obscure and relatively rare species (such as a bat) to gain access to the most common and widely distributed species of large animal on the planet — humans — will be strongly selected for.
So we can expect future pandemics when animal viruses spill over into humans, just as they have done in the past.
What is a semiconductor? An electrical engineer explains how these critical electronic components work and how they are made